TOKYO -- Chemical and materials group AGC has started producing an additive for a coronavirus vaccine candidate being developed by U.S. company Novavax, the Japanese manufacturer said Thursday.
Coronavirus
Novavax taps Japan's AGC to make ingredient in COVID-19 shot
Manufacturer produces compound for boosting vaccine candidate's effectiveness
Novavax's COVID-19 candidate vaccine is administered to a clinical trial participant in Australia in this Australian Broadcasting Corp. image. (Photo courtesy of Novavax)
Read Next
Latest on Coronavirus
